{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:28:56Z","timestamp":1782210536568,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/dmd.124.001917","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T18:15:12Z","timestamp":1730225712000},"page":"100010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characterization of human alcohol dehydrogenase 4 and aldehyde dehydrogenase 2 as enzymes involved in the formation of 5-carboxylpirfenidone, a major metabolite of pirfenidone"],"prefix":"10.1016","volume":"53","author":[{"given":"Rei","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0662-2241","authenticated-orcid":false,"given":"Yongjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.124.001917_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bcp.2018.03.002","article-title":"Identification of enzymes responsible for dantrolene metabolism in the human liver: a clue to uncover the cause of liver injury","volume":"151","author":"Amano","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001917_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/dmd.113.056374","article-title":"Why do most human liver cytosol preparations lack xanthine oxidase activity?","volume":"42","author":"Barr","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001917_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/hep.1840060330","article-title":"Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism","volume":"6","author":"Bosron","year":"1986","journal-title":"Hepatology"},{"key":"10.1124\/dmd.124.001917_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A\u00a0rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.124.001917_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2008.10.058","article-title":"The human short-chain dehydrogenase\/reductase (SDR) superfamily: a bioinformatics summary","volume":"178","author":"Bray","year":"2009","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.124.001917_bib6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cell.2018.03.062","article-title":"Transcriptome-wide interrogation of the functional intronome by spliceosome profiling","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"10.1124\/dmd.124.001917_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1208\/s12248-020-00536-y","article-title":"The role of alcohol dehydrogenase in drug metabolism: beyond ethanol oxidation","volume":"23","author":"Di","year":"2021","journal-title":"AAPS J"},{"key":"10.1124\/dmd.124.001917_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0006-2952(99)00065-9","article-title":"Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family","volume":"58","author":"Duester","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001917_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00008571-199902000-00004","article-title":"Polymorphism of the human alcohol dehydrogenase 4 (ADH4) promoter affects gene expression","volume":"9","author":"Edenberg","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.124.001917_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-pharmtox-052220-105907","article-title":"Non-P450 drug-metabolizing enzymes: contribution to drug disposition, toxicity, and development","volume":"62","author":"Fukami","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.124.001917_bib11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)00956-5","article-title":"Structure and function of xanthine oxidoreductase: where are we now?","volume":"33","author":"Harrison","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/dmd.124.001917_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1165\/rcmb.2005-0452OC","article-title":"Pirfenidone modulates airway responsiveness, inflammation, and remodeling after repeated challenge","volume":"35","author":"Hirano","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/dmd.124.001917_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0033-1341478","article-title":"Pharmacokinetics, safety and tolerability of pirfenidone and its major metabolite after single and multiple oral doses in healthy Chinese subjects under fed conditions","volume":"63","author":"Huang","year":"2013","journal-title":"Drug Res (Stuttg)"},{"key":"10.1124\/dmd.124.001917_bib14","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/acs.chemrestox.5b00129","article-title":"Comparison of the reactivity of trapping reagents toward electrophiles: cysteine derivatives can be bifunctional trapping reagents","volume":"28","author":"Inoue","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.124.001917_bib15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/dmd.110.037259","article-title":"CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay","volume":"39","author":"Iwamura","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001917_bib16","article-title":"UW is superior to Celsior and HTK in the protection of human liver endothelial cells against preservation injury","volume":"10","author":"Janssen","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1124\/dmd.124.001917_bib17","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1021\/bi9521093","article-title":"Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism","volume":"35","author":"Klyosov","year":"1996","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.124.001917_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1124\/dmd.111.043067","article-title":"Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse","volume":"40","author":"Kobayashi","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001917_bib19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/dmd.122.001198","article-title":"Development and validation of a proteomic correlation profiling technique to detect and identify enzymes involved in metabolism of drugs of concern","volume":"51","author":"Kudo","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001917_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.alcohol.2006.06.012","article-title":"Immunochemical features in the classification of human alcohol dehydrogenase family","volume":"39","author":"Lee","year":"2006","journal-title":"Alcohol"},{"key":"10.1124\/dmd.124.001917_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114458","article-title":"A\u00a0novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells","volume":"189","author":"Luo","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001917_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12015-010-9208-4","article-title":"The role of human aldehyde dehydrogenase in normal and cancer stem cells","volume":"7","author":"Ma","year":"2011","journal-title":"Stem Cell Rev"},{"key":"10.1124\/dmd.124.001917_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/00498254.2016.1144896","article-title":"Stereoselective hydroxylation by CYP2C19 and oxidation by ADH4 in the in\u00a0vitro metabolism of tivantinib","volume":"46","author":"Nishiya","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.124.001917_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/10408440591002183","article-title":"Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health","volume":"35","author":"O'Brien","year":"2005","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/dmd.124.001917_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152648","article-title":"Human superoxide dismutase 1 attenuates quinoneimine metabolite formation from mefenamic acid","volume":"448","author":"Ogiso","year":"2021","journal-title":"Toxicology"},{"key":"10.1124\/dmd.124.001917_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12858-016-0072-y","article-title":"Computational studies of human class V alcohol dehydrogenase - the odd sibling","volume":"17","author":"\u00d6stberg","year":"2016","journal-title":"BMC Biochem"},{"key":"10.1124\/dmd.124.001917_bib27","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/0006-2952(75)90087-8","article-title":"Human liver alcohol dehydrogenase: inhibition of methanol activity by pyrazole, 4-methylpyrazole, 4-hydroxymethylpyrazole and 4-carboxypyrazole","volume":"24","author":"Pietruszko","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001917_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2010.03.013","article-title":"Identification of a FOXA-dependent enhancer of human alcohol dehydrogenase 4 (ADH4)","volume":"460","author":"Pochareddy","year":"2010","journal-title":"Gene"},{"key":"10.1124\/dmd.124.001917_bib29","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1124\/dmd.124.001917_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jbt.10057","article-title":"Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact","volume":"17","author":"Sl\u00e1dek","year":"2003","journal-title":"J\u00a0Biochem Mol Toxicol"},{"key":"10.1124\/dmd.124.001917_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00204-016-1683-1","article-title":"Structure and function of mammalian aldehyde oxidases","volume":"90","author":"Terao","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.124.001917_bib32","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0006-2952(97)00359-6","article-title":"Inhibition of human mitochondrial aldehyde dehydrogenase by the disulfiram metabolite S-methyl-N,N-diethylthiocarbamoyl sulfoxide: structural characterization of the enzyme adduct by HPLC-tandem mass spectrometry","volume":"54","author":"Tomlinson","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.124.001917_bib33","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1021\/acs.molpharmaceut.1c00053","article-title":"Influence of proteome profiles and intracellular drug exposure on differences in CYP activity in donor-matched human liver microsomes and hepatocytes","volume":"18","author":"Wegler","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.124.001917_bib34","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1007\/s12032-011-0126-3","article-title":"Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinoma","volume":"29","author":"Wei","year":"2012","journal-title":"Med Oncol"},{"key":"10.1124\/dmd.124.001917_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.124.001917_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00498254.2021.2007553","article-title":"Pirfenidone 5-hydroxylation is mainly catalysed by CYP1A2 and partly catalysed by CYP2C19 and CYP2D6 in the human liver","volume":"51","author":"Zhang","year":"2021","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.124.001917_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bcp.2018.10.012","article-title":"CYP1A1 and 1B1-mediated metabolic pathways of dolutegravir, an HIV integrase inhibitor","volume":"158","author":"Zhu","year":"2018","journal-title":"Biochem Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624148507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.124.001917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:35:13Z","timestamp":1761194113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624148507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0090955624148507"],"URL":"https:\/\/doi.org\/10.1124\/dmd.124.001917","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of human alcohol dehydrogenase 4 and aldehyde dehydrogenase 2 as enzymes involved in the formation of 5-carboxylpirfenidone, a major metabolite of pirfenidone","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.124.001917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100010"}}